1. Home
  2. WLFC vs NVCR Comparison

WLFC vs NVCR Comparison

Compare WLFC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLFC
  • NVCR
  • Stock Information
  • Founded
  • WLFC 1985
  • NVCR 2000
  • Country
  • WLFC United States
  • NVCR Switzerland
  • Employees
  • WLFC N/A
  • NVCR N/A
  • Industry
  • WLFC Industrial Specialties
  • NVCR Medical/Dental Instruments
  • Sector
  • WLFC Consumer Discretionary
  • NVCR Health Care
  • Exchange
  • WLFC Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • WLFC 1.2B
  • NVCR 1.4B
  • IPO Year
  • WLFC 1996
  • NVCR 2015
  • Fundamental
  • Price
  • WLFC $149.51
  • NVCR $13.00
  • Analyst Decision
  • WLFC
  • NVCR Buy
  • Analyst Count
  • WLFC 0
  • NVCR 7
  • Target Price
  • WLFC N/A
  • NVCR $28.79
  • AVG Volume (30 Days)
  • WLFC 45.0K
  • NVCR 1.4M
  • Earning Date
  • WLFC 11-03-2025
  • NVCR 10-29-2025
  • Dividend Yield
  • WLFC 0.66%
  • NVCR N/A
  • EPS Growth
  • WLFC 30.03
  • NVCR N/A
  • EPS
  • WLFC 16.84
  • NVCR N/A
  • Revenue
  • WLFC $637,163,000.00
  • NVCR $630,160,000.00
  • Revenue This Year
  • WLFC $16.17
  • NVCR $6.68
  • Revenue Next Year
  • WLFC $4.88
  • NVCR $7.01
  • P/E Ratio
  • WLFC $8.95
  • NVCR N/A
  • Revenue Growth
  • WLFC 32.40
  • NVCR 14.58
  • 52 Week Low
  • WLFC $119.93
  • NVCR $10.87
  • 52 Week High
  • WLFC $235.43
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • WLFC 51.21
  • NVCR 56.24
  • Support Level
  • WLFC $146.23
  • NVCR $12.53
  • Resistance Level
  • WLFC $155.00
  • NVCR $13.24
  • Average True Range (ATR)
  • WLFC 4.06
  • NVCR 0.59
  • MACD
  • WLFC -0.08
  • NVCR 0.15
  • Stochastic Oscillator
  • WLFC 52.72
  • NVCR 65.82

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: